These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9665451)

  • 1. False-positive LSD drug screening induced by a mucolytic medication.
    Lotz J; Hafner G; Röhrich J; Zörntlein S; Kern T; Prellwitz W
    Clin Chem; 1998 Jul; 44(7):1580-1. PubMed ID: 9665451
    [No Abstract]   [Full Text] [Related]  

  • 2. False-positive LSD testing in urine samples from intensive care patients.
    Röhrich J; Zörntlein S; Lotz J; Becker J; Kern T; Rittner C
    J Anal Toxicol; 1998 Sep; 22(5):393-5. PubMed ID: 9737335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD screening in urine performed by CEDIA® LSD assay: positive interference with sertraline.
    Citterio-Quentin A; Seidel E; Ramuz L; Parant F; Moulsma M
    J Anal Toxicol; 2012 May; 36(4):289-90. PubMed ID: 22511703
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
    Grobosch T; Lemm-Ahlers U
    J Anal Toxicol; 2002 Apr; 26(3):181-6. PubMed ID: 11991536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry.
    Bodin K; Svensson JO
    Ther Drug Monit; 2001 Aug; 23(4):389-93. PubMed ID: 11477321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication.
    Gagajewski A; Davis GK; Kloss J; Poch GK; Anderson CJ; Apple FS
    Clin Chem; 2002 Jan; 48(1):205-6. PubMed ID: 11751564
    [No Abstract]   [Full Text] [Related]  

  • 8. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
    Verstraete AG; Van de Velde EJ
    Acta Clin Belg; 1999; 53 Suppl 1():94-6. PubMed ID: 10216992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of lysergide (LSD) and phencyclidine in biosamples.
    Schneider S; Kuffer P; Wennig R
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):189-200. PubMed ID: 9700559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability study of LSD under various storage conditions.
    Li Z; McNally AJ; Wang H; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):520-5. PubMed ID: 9788528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH; Magluilo J; Shannon KK; Smith ML
    J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine.
    Kerrigan S; Brooks DE
    Clin Chem; 1998 May; 44(5):985-90. PubMed ID: 9590371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
    Mardal M; Johansen SS; Thomsen R; Linnet K
    Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
    de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
    J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry.
    Skopp G; Pötsch L; Mattern R; Aderjan R
    Clin Chem; 2002 Sep; 48(9):1615-8. PubMed ID: 12194952
    [No Abstract]   [Full Text] [Related]  

  • 19. LSD Detection and Interpretation in Hair.
    Richeval C; Allorge D; Vanhoye X; Gaulier JM
    Curr Pharm Des; 2017; 23(36):5496-5501. PubMed ID: 28641537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.